Saturday, June 26, 2021

Live, Interactive Virtual Conference!
9:00 AM – 5:00 PM EST

The 5th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards will provide the latest information on important topics in malignancy assessment that can guide targeted therapy approaches for people diagnosed with cancers commonly encountered in clinical practice. From academic centers and community practices alike, pathologists and oncologists will come together to discuss recent advancements in diagnostic approaches and the impact of these advancements on treatment selection that ultimately affect patient outcomes. Our expert faculty will appraise clinical guidelines, explore new concepts and the latest research, and discuss ways for you to optimize molecular pathology techniques and apply them to clinical practice. This will be a dynamic experience, providing you with the opportunity to engage with faculty as they share their perspectives and personal experiences with clinical challenges in the field of pathology. A variety of formats will be used, including cutting-edge lectures, panel discussions, multidisciplinary tumor boards, and interactive question-and-answer sessions

• Expand your knowledge of new diagnostic techniques
• Hear about the latest research on emerging therapies
• Learn about new clinical trials
• Network with peers and colleagues
• Obtain insights on your most challenging cases

This educational program is directed toward pathologists and oncologists interested in the management of patients with cancer. Fellows, residents, nurse practitioners, nurses, physician assistants, investigators, and other health care professionals interested in the treatment of patients with cancer are also invited to attend.

Upon completion of this activity, participants should have improved their ability to:

• Determine testing strategies to facilitate precision diagnosis and stratify risk among patients with cancer
• Apply molecular markers to inform staging and monitoring in cancer care settings
• Discuss strategies to facilitate prognostic and predictive biomarkers identification via multidisciplinary coordination between pathology and oncology departments
• Integrate tumor biomarker information in parallel with recent clinical trial evidence to personalize treatment planning in multiple lines of care
• Identify patients who might benefit from clinical trial participation based on biomarker characterization of their tumors